Subjects were at least 40 years of age, had HbA1c 6.5%, and multiple risk factors (21% of randomized subjects) for cardiovascular disease (age 55 years for men and 60 years for women plus at least one additional risk factor of dyslipidemia, hypertension, or current cigarette smoking) or established (79% of the randomized subjects) cardiovascular disease defined as a history of ischemic heart disease, peripheral vascular disease, or ischemic stroke
The top three cholesterol binding sites, displaying the highest cholesterol residence times for both states, were calculated using the PyLipID package (Figure 2D, E)
Administered as a once-weekly GLP-1 Medications Prescribed Equally for Men and Women The misconception that GLP-1 medications are primarily for women comes from social media trends, not clinical reality
Recalls & Warnings January 10, 2023 Seller of CBD Warned for COVID-19 Claims On January 5, 2023, the FDA issued a warning to PharmaCanna after review of the companys website and social media, which found statements about the companys cannabidiol (CBD) product, CBDefense 2000, to be drug claims because they promoted the products to prevent or treat
Early-stage research continues, but clinical evidence does not yet support patches as a substitute for established injection or oral therapies
